Best Biotech Stocks To Buy In 2024
biotechExplore Stocklytics' meticulously researched selection of the Best Biotech Stocks to Buy in 2023, focusing on companies within the biotechnology sector. These picks highlight biotech stocks involved in pharmaceuticals, drug development, and healthcare innovations. Stocklytics identifies biotech stocks poised for growth, considering factors like innovative pipelines, regulatory approvals, and market demand. Whether you're interested in therapeutic breakthroughs, genetic research, or healthcare advancements, Stocklytics' selections offer opportunities to invest in companies driving innovation and potential breakthroughs in the biotech industry in the coming year.
| # | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MiMedx Group MDXG | $7.24 | arrow_drop_up0.55% | $1.08B | 512.00KAVG.932.89K | 13.92 | Neutralremove | - | 21.88% | 94 | AI Analysis | ||||
| 2 | Amylyx Pharmaceuticals AMLX | $1.89 | arrow_drop_down2.07% | $133.97M | 3.28MAVG.2.16M | 2.70 | Neutralremove | - | -93.72% | 82 | AI Analysis | ||||
| 3 |  Vertex Pharmaceuticals VRTX | $418.98 | arrow_drop_up0.04% | $103.66B | 676.20KAVG.1.17M | 27.15 | Neutralremove | - | 21.50% | 81 | AI Analysis | ||||
| 4 |  BioMarin Pharmaceutical BMRN | $81.72 | arrow_drop_down0.13% | $15.53B | 1.15MAVG.1.52M | 77.09 | Neutralremove | - | -14.52% | 77 | AI Analysis | ||||
| 5 |  Incyte INCY | $53.50 | arrow_drop_down0.01% | $11.60B | 1.42MAVG.2.39M | 16.21 | Neutralremove | - | -17.40% | 74 | AI Analysis | ||||
| 6 | Innoviva INVA | $15.29 | arrow_drop_down1.73% | $960.90M | 511.50KAVG.486.15K | 6.95 | Neutralremove | - | 32.26% | 74 | AI Analysis | ||||
| 7 | Halozyme Therapeutics HALO | $43.84 | arrow_drop_up4.35% | $5.19B | 1.44MAVG.1.07M | 20.87 | Neutralremove | - | 43.36% | 68 | AI Analysis | ||||
| 8 |  Exelixis EXEL | $21.76 | arrow_drop_up0.78% | $6.45B | 1.42MAVG.2.69M | 33.47 | Neutralremove | - | 13.15% | 68 | AI Analysis | ||||
| 9 |  Jazz Pharmaceuticals PLC JAZZ | $113.12 | arrow_drop_up2.18% | $6.93B | 812.10KAVG.742.88K | 23.42 | Neutralremove | - | -16.47% | 65 | AI Analysis | ||||
| 10 |  Bio-Techne TECH | $79.63 | arrow_drop_up3.34% | $12.14B | 816.10KAVG.1.45M | 63.70 | Neutralremove | 0.41% | -1.78% | 60 | AI Analysis |
About Best Biotech Stocks To Buy In 2024
Explore Stocklytics' meticulously researched selection of the Best Biotech Stocks to Buy in 2023, focusing on companies within the biotechnology sector. These picks highlight biotech stocks involved in pharmaceuticals, drug development, and healthcare innovations. Stocklytics identifies biotech stocks poised for growth, considering factors like innovative pipelines, regulatory approvals, and market demand. Whether you're interested in therapeutic breakthroughs, genetic research, or healthcare advancements, Stocklytics' selections offer opportunities to invest in companies driving innovation and potential breakthroughs in the biotech industry in the coming year.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.